NCT06332508 2026-03-13
Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)
National University Hospital, Singapore
Phase 1 Completed
Clinical Trials
16 trialsNCT06802757 2026-02-25
PRISM-TNBC
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT06443645 2026-02-04
SCARA-B
Centre Paul Strauss
Recruiting
NCT04335669 2025-09-12
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
Lund University Hospital
Phase 3 Active not recruiting
NCT02521363 2025-08-22
Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT02299999 2025-01-15
SAFIR02_Breast
UNICANCER
Phase 2 Active not recruiting
NCT04109066 2025-01-08
CheckMate 7FL
Bristol-Myers Squibb
Phase 3 Completed
NCT06684054 2024-11-12
STFREiYTNBC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting
NCT00712881 2024-02-23
Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT02679040 2023-07-03
HIST-RIC
Institut Paoli-Calmettes
Phase 2 Unknown
NCT02549677 2022-10-27
ELEGANT
Ruijin Hospital
Phase 4 Completed
NCT04499118 2020-08-05
AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer
Sichuan Provincial People's Hospital
Phase 2 Unknown
NCT02561832 2019-02-20
A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer
AstraZeneca
Phase 1 Terminated
NCT00912444 2016-11-22
NATT
Shanghai Jiao Tong University School of Medicine
Phase 3 Terminated
NCT00352378 2011-06-27
Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
National Cancer Center, Korea
Phase 3 Completed